1.54 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
BioNexus Gene Lab Corp Common stock (BGLC) is currently trading at $1.55. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest BGLC is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Aug 5, 2026.